29 Result(s)

Article

Directionality of non-permissive HLA-DPB1 T-cell epitope group mismatches does not improve clinical risk stratification in 8/8 matched unrelated donor hematopoietic cell transplantation

In 8/8 HLA-matched unrelated donor (UD) hematopoietic cell transplants (HCT), HLA-DPB1 mismatches between alleles from different T-cell epitope (TCE) groups (non-permissive mismatches) are associated with sign...

K Fleischhauer, K W Ahn, H L Wang, L Zito, P Crivello… in Bone Marrow Transplantation (2017)

Article

YKL-40 in allogeneic hematopoietic cell transplantation after AML and myelodysplastic syndrome

YKL-40, also called chitinase-3-like-1 protein, is an inflammatory biomarker that has been associated with disease severity in inflammatory and malignant diseases, including AML, multiple myeloma and lymphomas...

B Kornblit, T Wang, S J Lee, S R Spellman, X Zhu… in Bone Marrow Transplantation (2016)

Article

Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas

Allogeneic hematopoietic cell transplantation (HCT) offers the chance of cure for patients with non-transformed follicular lymphoma (FL), but is associated with the risk of non-relapse mortality (NRM). The aim...

F Heinzelmann, W Bethge, D W Beelen, M Engelhard, N Kröger… in Bone Marrow Transplantation (2016)

Article

Related hematopoietic cell donor care: is there a role for unrelated donor registries?

In almost half of allogeneic hematopoietic progenitor cell (HPC) transplants, a related donor (RD) is used, yet a lack of standardized guidelines means that their care is heterogeneous. Changes to regulatory s...

C Anthias, S M van Walraven, B S Sørensen, G N de Faveri… in Bone Marrow Transplantation (2015)

Article

3D visualization of the regional differences

J Ellegood, E Anagnostou, B A Babineau, J N Crawley, L Lin… in Molecular Psychiatry (2015)

Article

Clustering autism: using neuroanatomical differences in 26 mouse models to gain insight into the heterogeneity

Autism is a heritable disorder, with over 250 associated genes identified to date, yet no single gene accounts for >1–2% of cases. The clinical presentation, behavioural symptoms, imaging and histopathology fi...

J Ellegood, E Anagnostou, B A Babineau, J N Crawley, L Lin… in Molecular Psychiatry (2015)

Article

ATR controls cellular adaptation to hypoxia through positive regulation of hypoxia-inducible factor 1 (HIF-1) expression

Tumor cells adaptation to severe oxygen deprivation (hypoxia) plays a major role in tumor progression. The transcription factor HIF-1 (hypoxia-inducible factor 1), whose α-subunit is stabilized under hypoxic c...

F Fallone, S Britton, L Nieto, B Salles, C Muller in Oncogene (2013)

Article

Urinary NT-proBNP and ductal closure in preterm infants

To explore the association of urinary N-terminal pro-brain natriuretic peptide (NT-proBNP) concentrations and closure of patent ductus arteriosus (PDA) in preterm infants.

C Czernik, B Metze, C Müller, C Bührer in Journal of Perinatology (2013)

Article

Information technology and the role of WMDA in promoting standards for international exchange of hematopoietic stem cell donors and products

Nearly half of the unrelated hematopoietic SCTs facilitated worldwide involves an exchange of products between countries. The process is information intensive and requires coordination through regional hubs of...

M Maiers, J N A Bakker, W Bochtler, H-P Eberhard… in Bone Marrow Transplantation (2010)

Article

Cord blood banks collect units with different HLA alleles and haplotypes to volunteer donor banks: a comparative report from Swiss Blood stem cells

Allogeneic haematopoietic SCT is a standard therapy for many patients with haematological diseases. A major aim of public umbilical cord blood (UCB) banking is to establish an inventory with a large HLA divers...

S Meyer-Monard, J Passweg, C Troeger, H-P Eberhard… in Bone Marrow Transplantation (2009)

Article

Acid sphingomyelinase deficiency protects from cisplatin-induced gastrointestinal damage

Cisplatin is one of the most effectively used chemotherapeutic agents for cancer treatment. However, in humans, important cytotoxic side effects are observed including dose-limiting renal damage and profound g...

A Rebillard, N Rioux-Leclercq, C Muller, P Bellaud, F Jouan, O Meurette… in Oncogene (2008)

Article

Incorporation of the bone marker carboxy-terminal telopeptide of type-1 collagen improves prognostic information of the International Staging System in newly diagnosed symptomatic multiple myeloma

Several prognostic markers, including parameters of tumor burden and cytogenetics, were adopted to identify high-risk patients in multiple myeloma (MM). Recently, the International Staging System (ISS), includ...

C Jakob, J Sterz, P Liebisch, M Mieth, J Rademacher, A Goerke, U Heider… in Leukemia (2008)

Article

Determination of ergot alkaloids in rye and rye flour

An effective and timesaving analytical method was developed for the determination of 12 ergot alkaloids (ergometrine, ergotamine, ergocristine, α-ergokryptine, ergosine, ergocornine, and their respective -inin...

C. Müller, H. S. Klaffke, W. Krauthause, R. Wittkowski in Mycotoxin Research (2006)

Article

A special report: suggested procedures for international unrelated donor search from the donor registries and quality assurance working groups of the World Marrow Donor Association (WMDA)

This special report details the World Marrow Donor Association's recommended procedures regarding the international search for an unrelated donor for hematopoietic stem cell transplantation. The responsibiliti...

T Wiegand, C Raffoux, C K Hurley, M Kern, M Oudshoorn… in Bone Marrow Transplantation (2004)

Article

Donor and liability insurance of donor registries, donor centers, and collection centers – recommendations

The article presents views and recommendations of the World Marrow Donor Association regarding the need for donor and liability insurance for hematopoietic stem cell donor registries, and donor and collection ...

T Egeland, J Lie, U Persson, J Raymond, C Müller in Bone Marrow Transplantation (2004)

Article

Treatment of HBV-carrying lymphoma patients with Rituximab and CHOP: a diagnostic and therapeutic challenge

C Skrabs, C Müller, H Agis, C Mannhalter, U Jäger in Leukemia (2002)